RU2016143751A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016143751A3 RU2016143751A3 RU2016143751A RU2016143751A RU2016143751A3 RU 2016143751 A3 RU2016143751 A3 RU 2016143751A3 RU 2016143751 A RU2016143751 A RU 2016143751A RU 2016143751 A RU2016143751 A RU 2016143751A RU 2016143751 A3 RU2016143751 A3 RU 2016143751A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Oncology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10251690.3 | 2010-09-30 | ||
| EP10251690 | 2010-09-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013112666/15A Division RU2604690C2 (ru) | 2010-09-30 | 2011-09-29 | Фармацевтическая композиция |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016143751A RU2016143751A (ru) | 2018-12-18 |
| RU2016143751A3 true RU2016143751A3 (https=) | 2020-01-16 |
| RU2737264C2 RU2737264C2 (ru) | 2020-11-26 |
Family
ID=43478408
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016143751A RU2737264C2 (ru) | 2010-09-30 | 2011-09-29 | Фармацевтическая композиция |
| RU2013112666/15A RU2604690C2 (ru) | 2010-09-30 | 2011-09-29 | Фармацевтическая композиция |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013112666/15A RU2604690C2 (ru) | 2010-09-30 | 2011-09-29 | Фармацевтическая композиция |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US9566311B2 (https=) |
| EP (5) | EP2621468B1 (https=) |
| JP (2) | JP6038797B2 (https=) |
| KR (2) | KR101919119B1 (https=) |
| CN (4) | CN104906032A (https=) |
| AU (1) | AU2011309762B2 (https=) |
| BR (2) | BR122021001123B1 (https=) |
| CA (1) | CA2812510A1 (https=) |
| CY (2) | CY1119245T1 (https=) |
| DK (4) | DK2621468T3 (https=) |
| ES (4) | ES2905561T3 (https=) |
| FI (1) | FI4374878T3 (https=) |
| HR (3) | HRP20171256T1 (https=) |
| HU (4) | HUE034367T2 (https=) |
| IL (3) | IL225238B (https=) |
| JO (3) | JO3400B1 (https=) |
| LT (3) | LT4374878T (https=) |
| MX (3) | MX395271B (https=) |
| NZ (1) | NZ609719A (https=) |
| PL (4) | PL4374878T3 (https=) |
| PT (4) | PT3222272T (https=) |
| RS (3) | RS66759B1 (https=) |
| RU (2) | RU2737264C2 (https=) |
| SI (4) | SI3222272T1 (https=) |
| SM (3) | SMT202500165T1 (https=) |
| TW (6) | TWI750934B (https=) |
| WO (1) | WO2012042371A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| JP2015516415A (ja) * | 2012-05-08 | 2015-06-11 | ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ | 化学修飾ヘパリンまたはヘパラン硫酸および子宮収縮剤を用いた分娩後出血の処置 |
| ES2970059T3 (es) * | 2014-09-19 | 2024-05-24 | Ferring Bv | Método de tratamiento del síndrome de Prader-Willi |
| RU2701199C2 (ru) | 2014-10-01 | 2019-09-25 | Окситон Байосайенс Б.В. | Перорально распадающаяся твердая фармацевтическая единица дозирования, содержащая контролирующее родовую деятельность вещество |
| PL3200764T3 (pl) | 2014-10-01 | 2020-12-28 | Oxytone Bioscience B.V. | Rozpadająca się w jamie ustnej stała farmaceutyczna jednostka dawkowania zawierająca substancję kontrolującą poród |
| SG11201705591PA (en) | 2015-01-07 | 2017-08-30 | Trigemina Inc | Magnesium-containing oxytocin formulations and methods of use |
| WO2016162819A1 (en) * | 2015-04-07 | 2016-10-13 | Lupin Limited | Stable aqueous pharmaceutical composition of anti-tnf alpha antibody |
| HUE070412T2 (hu) | 2016-04-12 | 2025-06-28 | Tonix Pharma Ltd | Magnézium tartalmú oxitocin készítmények és alkamazási eljárásaik |
| CN107773531B (zh) * | 2016-08-31 | 2021-05-04 | 成都倍特药业股份有限公司 | 一种马来酸麦角新碱注射液 |
| CN108236601B (zh) * | 2016-12-23 | 2020-04-17 | 深圳翰宇药业股份有限公司 | 一种稳定的含卡贝缩宫素的阴道给药的药用组合物及其制备方法 |
| BR112020001832A2 (pt) * | 2017-08-11 | 2020-07-28 | Ferring B.V. | método de produção de uma composição farmacêuti-ca |
| GB201721846D0 (en) * | 2017-12-22 | 2018-02-07 | Arecor Ltd | Novel composition |
| EP3759121A1 (en) | 2018-03-01 | 2021-01-06 | Trigemina, Inc. | Labeled oxytocin and method of manufacture and use |
| CN108721598B (zh) * | 2018-07-03 | 2020-06-05 | 北京市新里程医药科技有限公司 | 一种缩宫素原料的制备方法及其药物组合物和制剂 |
| EP3852724A4 (en) | 2018-09-20 | 2022-07-06 | Levo Therapeutics, Inc. | CARBETOCIN DRUG PRODUCT AND PROCESS FOR ITS MANUFACTURE |
| TW202031283A (zh) * | 2018-09-20 | 2020-09-01 | 馬克 Ｃ 曼寧 | 穩定卡貝縮宮素鼻內製劑 |
| CN109745544B (zh) * | 2018-11-23 | 2024-11-08 | 南京新百药业有限公司 | 稳定的缩宫素药物组合物及其制备方法 |
| US20220080023A1 (en) * | 2018-12-21 | 2022-03-17 | Arecor Limited | Novel composition |
| JP7390031B2 (ja) * | 2018-12-27 | 2023-12-01 | 国立大学法人金沢大学 | オキシトシン誘導体及びその使用 |
| KR20220011697A (ko) | 2019-05-22 | 2022-01-28 | 바이오비에 아이앤씨. | 테를리프레신 제형 |
| CN110308222A (zh) * | 2019-07-17 | 2019-10-08 | 武汉赛沃医药科技有限公司 | 一种卡贝缩宫素原料药有关物质检测方法 |
| CN110403904A (zh) * | 2019-07-26 | 2019-11-05 | 翔宇药业股份有限公司 | 卡贝缩宫素注射液及其应用 |
| CN110237230A (zh) * | 2019-07-31 | 2019-09-17 | 南京康舟医药科技有限公司 | 一种卡贝缩宫素药物组合物及其制备方法 |
| JP2023500763A (ja) * | 2019-11-04 | 2023-01-11 | フェリング ベスローテン フェンノートシャップ | 泌乳の改善のためのメロトシンの鼻腔内投与 |
| CN111012739A (zh) * | 2019-12-04 | 2020-04-17 | 长春圣金诺生物制药有限公司 | 一种可以常温储存的含卡贝缩宫素及稳定剂的注射液 |
| ES3010259T3 (en) | 2021-03-26 | 2025-04-01 | Ot4B | Treatment of dysphagia |
| CN114191388B (zh) * | 2021-12-27 | 2023-06-09 | 苏州天马医药集团天吉生物制药有限公司 | 一种卡贝缩宫素制剂的制备方法 |
| CN114712483B (zh) * | 2022-05-12 | 2023-09-29 | 成都倍特药业股份有限公司 | 一种麦角新碱缩宫素复方注射液及其制备方法和用途 |
| WO2024211393A2 (en) | 2023-04-04 | 2024-10-10 | Tulex Pharmaceuticals Inc. | Desmopressin oral compositions |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
| CN1109558A (zh) * | 1994-11-07 | 1995-10-04 | 马文亮 | 装有压力表的双管气筒 |
| SE9604341D0 (sv) * | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
| DE69719189T2 (de) | 1997-11-18 | 2003-11-27 | Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria | Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten |
| US6333313B1 (en) | 1998-10-29 | 2001-12-25 | Board Of Regents, The University Of Texas System | Clinical use of oxytocin alone or in combination to treat bone disorders |
| US20070032410A1 (en) * | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
| US6894026B1 (en) * | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
| JP2001233787A (ja) * | 2000-02-04 | 2001-08-28 | Patents Exploitation Co Bv | 小・中サイズのペプチド含有薬学的組成物 |
| AT409081B (de) | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
| JP5290489B2 (ja) | 2001-11-08 | 2013-09-18 | アッヴィ・バイオセラピューティクス・インコーポレイテッド | Ｉｇｇ抗体の安定な液体医薬製剤 |
| EP1556068B1 (en) | 2002-10-03 | 2010-08-18 | Neuropharmacology Services, LLC | Oxytocin for use in the treatment of Autism and Asperger's disorder |
| DE602004019761D1 (de) | 2003-01-08 | 2009-04-16 | Novartis Vaccines & Diagnostic | Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante |
| US20100143485A1 (en) | 2003-03-05 | 2010-06-10 | Hudnut Paul S | Oxycontin controlled release formulations and methods of using same |
| GT200600031A (es) * | 2005-01-28 | 2006-08-29 | Formulacion anticuerpo anti a beta | |
| CA2689476C (en) * | 2007-06-07 | 2014-08-05 | Nastech Pharmaceutical Company Inc. | Intranasal carbetocin formulations and methods for the treatment of autism |
| ES2355196T3 (es) | 2007-07-02 | 2011-03-23 | Sime Darby Malaysia Berhad | Composición de grasa para la fritura. |
| ES2319054B1 (es) * | 2007-08-06 | 2010-02-12 | Gp Pharm S.A. | Composicion farmaceutica oral de desmopresina. |
| EP2260053B1 (en) * | 2008-03-31 | 2014-05-14 | Ferring BV | Oxytocin analogues |
| JP5643762B2 (ja) * | 2008-10-15 | 2014-12-17 | インターシア セラピューティクス，インコーポレイティド | 高濃度薬物粒子、製剤、懸濁液、及びこれらの使用 |
-
2011
- 2011-09-28 JO JOP/2011/0297A patent/JO3400B1/ar active
- 2011-09-29 NZ NZ609719A patent/NZ609719A/en unknown
- 2011-09-29 RU RU2016143751A patent/RU2737264C2/ru active
- 2011-09-29 PT PT171693286T patent/PT3222272T/pt unknown
- 2011-09-29 TW TW109142907A patent/TWI750934B/zh active
- 2011-09-29 HU HUE11776530A patent/HUE034367T2/en unknown
- 2011-09-29 PT PT241664176T patent/PT4374878T/pt unknown
- 2011-09-29 DK DK11776530.5T patent/DK2621468T3/en active
- 2011-09-29 SI SI201132022T patent/SI3222272T1/sl unknown
- 2011-09-29 BR BR122021001123-0A patent/BR122021001123B1/pt active IP Right Grant
- 2011-09-29 HR HRP20171256TT patent/HRP20171256T1/hr unknown
- 2011-09-29 TW TW100135257A patent/TWI532507B/zh active
- 2011-09-29 TW TW108110519A patent/TWI746951B/zh active
- 2011-09-29 DK DK17169328.6T patent/DK3222272T3/da active
- 2011-09-29 BR BR112013007362-4A patent/BR112013007362B1/pt active IP Right Grant
- 2011-09-29 RS RS20250410A patent/RS66759B1/sr unknown
- 2011-09-29 ES ES17169328T patent/ES2905561T3/es active Active
- 2011-09-29 PL PL24166417.6T patent/PL4374878T3/pl unknown
- 2011-09-29 EP EP11776530.5A patent/EP2621468B1/en active Active
- 2011-09-29 HU HUE17169301A patent/HUE057187T2/hu unknown
- 2011-09-29 CN CN201510212609.XA patent/CN104906032A/zh active Pending
- 2011-09-29 TW TW106115818A patent/TWI680773B/zh active
- 2011-09-29 LT LTEP24166417.6T patent/LT4374878T/lt unknown
- 2011-09-29 SM SM20250165T patent/SMT202500165T1/it unknown
- 2011-09-29 PT PT117765305T patent/PT2621468T/pt unknown
- 2011-09-29 RU RU2013112666/15A patent/RU2604690C2/ru active
- 2011-09-29 HR HRP20250382TT patent/HRP20250382T1/hr unknown
- 2011-09-29 WO PCT/IB2011/002394 patent/WO2012042371A2/en not_active Ceased
- 2011-09-29 EP EP21192651.4A patent/EP3936117A1/en active Pending
- 2011-09-29 LT LTEP17169328.6T patent/LT3222272T/lt unknown
- 2011-09-29 EP EP17169301.3A patent/EP3246018B1/en active Active
- 2011-09-29 CA CA2812510A patent/CA2812510A1/en not_active Abandoned
- 2011-09-29 RS RS20170827A patent/RS56220B1/sr unknown
- 2011-09-29 SI SI201131272T patent/SI2621468T1/sl unknown
- 2011-09-29 MX MX2016014747A patent/MX395271B/es unknown
- 2011-09-29 PL PL17169328T patent/PL3222272T3/pl unknown
- 2011-09-29 US US13/824,132 patent/US9566311B2/en active Active
- 2011-09-29 SM SM20220034T patent/SMT202200034T1/it unknown
- 2011-09-29 CN CN201610930206.3A patent/CN107080832B/zh active Active
- 2011-09-29 KR KR1020137010256A patent/KR101919119B1/ko active Active
- 2011-09-29 FI FIEP24166417.6T patent/FI4374878T3/fi active
- 2011-09-29 CN CN201610930541.3A patent/CN107412728A/zh active Pending
- 2011-09-29 RS RS20220052A patent/RS62873B1/sr unknown
- 2011-09-29 HU HUE17169328A patent/HUE056835T2/hu unknown
- 2011-09-29 LT LTEP11776530.5T patent/LT2621468T/lt unknown
- 2011-09-29 DK DK24166417.6T patent/DK4374878T3/da active
- 2011-09-29 SM SM20170420T patent/SMT201700420T1/it unknown
- 2011-09-29 PL PL11776530T patent/PL2621468T3/pl unknown
- 2011-09-29 MX MX2013003365A patent/MX352949B/es active IP Right Grant
- 2011-09-29 TW TW104135836A patent/TWI661834B/zh active
- 2011-09-29 HR HRP20211969TT patent/HRP20211969T1/hr unknown
- 2011-09-29 CN CN2011800464547A patent/CN103124554A/zh active Pending
- 2011-09-29 EP EP24166417.6A patent/EP4374878B1/en active Active
- 2011-09-29 DK DK17169301.3T patent/DK3246018T3/da active
- 2011-09-29 EP EP17169328.6A patent/EP3222272B1/en not_active Revoked
- 2011-09-29 ES ES17169301T patent/ES2902418T3/es active Active
- 2011-09-29 MX MX2016005537A patent/MX390779B/es unknown
- 2011-09-29 PL PL17169301T patent/PL3246018T3/pl unknown
- 2011-09-29 PT PT171693013T patent/PT3246018T/pt unknown
- 2011-09-29 HU HUE24166417A patent/HUE070972T2/hu unknown
- 2011-09-29 SI SI201132035T patent/SI3246018T1/sl unknown
- 2011-09-29 SI SI201132130T patent/SI4374878T1/sl unknown
- 2011-09-29 TW TW104135841A patent/TWI650134B/zh not_active IP Right Cessation
- 2011-09-29 AU AU2011309762A patent/AU2011309762B2/en active Active
- 2011-09-29 ES ES24166417T patent/ES3027637T3/es active Active
- 2011-09-29 KR KR1020187032634A patent/KR102102664B1/ko not_active Expired - Fee Related
- 2011-09-29 JP JP2013530810A patent/JP6038797B2/ja active Active
- 2011-09-29 ES ES11776530.5T patent/ES2637988T3/es active Active
-
2013
- 2013-03-14 IL IL225238A patent/IL225238B/en active IP Right Grant
-
2016
- 2016-04-27 IL IL245328A patent/IL245328B/en unknown
- 2016-04-27 IL IL245326A patent/IL245326B/en active IP Right Grant
- 2016-11-02 JP JP2016215212A patent/JP6250770B2/ja active Active
- 2016-12-28 US US15/393,053 patent/US20170106044A1/en not_active Abandoned
- 2016-12-28 US US15/393,026 patent/US20170106043A1/en not_active Abandoned
-
2017
- 2017-08-23 CY CY20171100893T patent/CY1119245T1/el unknown
-
2018
- 2018-11-12 JO JOP/2018/0103A patent/JOP20180103B1/ar active
- 2018-11-12 JO JOP/2018/0102A patent/JOP20180102B1/ar active
-
2022
- 2022-02-01 CY CY20221100079T patent/CY1124924T1/el unknown
- 2022-07-12 US US17/863,319 patent/US20230124105A1/en not_active Abandoned